- Home
- CDNA vs COMM Comparison
CDNA vs COMM Comparison
Compare CDNA & COMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- COMM
- Stock Information
- Founded
- CDNA 1998
- COMM 1976
- Country
- CDNA United States
- COMM United States
- Employees
- CDNA N/A
- COMM N/A
- Industry
- CDNA Medical Specialities
- COMM Radio And Television Broadcasting And Communications Equipment
- Sector
- CDNA Health Care
- COMM Technology
- Exchange
- CDNA Nasdaq
- COMM Nasdaq
- Market Cap
- CDNA 1.0B
- COMM 1.1B
- IPO Year
- CDNA 2014
- COMM 2013
- Fundamental
- Price
- CDNA $15.00
- COMM $4.76
- Analyst Decision
- CDNA Buy
- COMM Hold
- Analyst Count
- CDNA 8
- COMM 4
- Target Price
- CDNA $28.14
- COMM $3.50
- AVG Volume (30 Days)
- CDNA 940.1K
- COMM 6.2M
- Earning Date
- CDNA 04-30-2025
- COMM 05-01-2025
- Dividend Yield
- CDNA N/A
- COMM N/A
- EPS Growth
- CDNA N/A
- COMM N/A
- EPS
- CDNA 1.07
- COMM 3.42
- Revenue
- CDNA $346,421,000.00
- COMM $4,417,100,000.00
- Revenue This Year
- CDNA $13.28
- COMM $21.62
- Revenue Next Year
- CDNA $15.13
- COMM $8.19
- P/E Ratio
- CDNA $13.96
- COMM $186.43
- Revenue Growth
- CDNA 25.92
- COMM 16.19
- 52 Week Low
- CDNA $7.42
- COMM $0.86
- 52 Week High
- CDNA $34.84
- COMM $7.19
- Technical
- Relative Strength Index (RSI)
- CDNA 31.37
- COMM 59.74
- Support Level
- CDNA $14.86
- COMM $3.55
- Resistance Level
- CDNA $18.71
- COMM $4.02
- Average True Range (ATR)
- CDNA 0.98
- COMM 0.28
- MACD
- CDNA -0.24
- COMM 0.18
- Stochastic Oscillator
- CDNA 3.08
- COMM 96.81
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).